CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.
about
Comprehensive evaluation of clinical efficacy and safety of celecoxib combined with chemotherapy in management of gastric cancer.GAPLINC is a predictor of poor prognosis and regulates cell migration and invasion in osteosarcomaPrognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
P2860
CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD44v6: A metastasis-associate ...... s with heterogeneity analysis.
@en
CD44v6: A metastasis-associate ...... s with heterogeneity analysis.
@nl
type
label
CD44v6: A metastasis-associate ...... s with heterogeneity analysis.
@en
CD44v6: A metastasis-associate ...... s with heterogeneity analysis.
@nl
prefLabel
CD44v6: A metastasis-associate ...... s with heterogeneity analysis.
@en
CD44v6: A metastasis-associate ...... s with heterogeneity analysis.
@nl
P2093
P2860
P1433
P1476
CD44v6: A metastasis-associate ...... s with heterogeneity analysis.
@en
P2093
Weidong Li
Zhicheng Zhao
P2860
P356
10.1097/MD.0000000000005603
P407
P577
2016-12-01T00:00:00Z